Status:
COMPLETED
A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer.
Lead Sponsor:
Tianshu Liu
Conditions:
Locally Advanced Gastric Cancer
Eligibility:
All Genders
18-80 years
Brief Summary
This study is designed to assess what is the better neoadjuvant chemotherapy regimen for patients with initially unresectable locally advanced gastric cancer.
Eligibility Criteria
Inclusion
- more than 2 regional bulky lymph nodes macroscopic tumor type is either the Borrmann type 4 or large type 3 tumor invades adjacent structures (T4b)
Exclusion
- peritoneal metastasis confirmed by CT scan lung metastasis, liver metastasis, pleural effusion, and/or other distant metastasis
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
242 Patients enrolled
Trial Details
Trial ID
NCT02192983
Start Date
November 1 2008
End Date
May 1 2015
Last Update
December 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Zhongshan Ethics Committee
Shanghai, Shanghai Municipality, China